Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II StudyJournal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03555 ;PMID: 34292792Full text available |
2 |
Material Type: Article
|
![]() |
Colorectal Cancer Incidence Patterns in the United States, 1974-2013JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8) [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw322 ;PMID: 28376186Full text available |
3 |
Material Type: Article
|
![]() |
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal CancerJournal of clinical oncology, 2016-06, Vol.34 (18), p.2157-2164 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2015.65.9128 ;PMID: 27138577Full text available |
4 |
Material Type: Article
|
![]() |
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility QuotientJournal of clinical oncology, 2020-11, Vol.38 (32), p.3773-3784 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01255 ;PMID: 32931399Full text available |
5 |
Material Type: Article
|
![]() |
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerClinical cancer research, 2021-10, Vol.27 (20), p.5586-5594 [Peer Reviewed Journal]2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-21-0410 ;PMID: 33926918Full text available |
6 |
Material Type: Article
|
![]() |
Breast cancer statistics, 2019CA: a cancer journal for clinicians, 2019-11, Vol.69 (6), p.438-451 [Peer Reviewed Journal]2019 American Cancer Society ;2019 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2019 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21583 ;PMID: 31577379Full text available |
7 |
Material Type: Article
|
![]() |
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00174 ;PMID: 33872070Full text available |
8 |
Material Type: Article
|
![]() |
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate CancerJournal of clinical oncology, 2017-06, Vol.35 (17), p.1884-1890 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.71.7397 ;PMID: 28296582Full text available |
9 |
Material Type: Article
|
![]() |
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyJournal of clinical oncology, 2019-06, Vol.37 (18), p.1558-1565 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.00201 ;PMID: 31067138Full text available |
10 |
Material Type: Article
|
![]() |
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164Journal of clinical oncology, 2020-01, Vol.38 (1), p.11-19 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02107 ;PMID: 31725351Full text available |
11 |
Material Type: Article
|
![]() |
Cancer statistics, 2018CA: a cancer journal for clinicians, 2018-01, Vol.68 (1), p.7-30 [Peer Reviewed Journal]2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan-Feb 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21442 ;PMID: 29313949Full text available |
12 |
Material Type: Article
|
![]() |
Ovarian cancer statistics, 2018CA: a cancer journal for clinicians, 2018-07, Vol.68 (4), p.284-296 [Peer Reviewed Journal]2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jul/Aug 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21456 ;PMID: 29809280Full text available |
13 |
Material Type: Article
|
![]() |
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012Neuro-oncology (Charlottesville, Va.), 2015-10, Vol.17 Suppl 4 (suppl 4), p.iv1-iv62 [Peer Reviewed Journal]The Centers for Disease Control. Published by Oxford University Press on behalf of the Society for Neuro-Oncology in cooperation with the Central Brain Tumor Registry 2015 2015 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/nov189 ;PMID: 26511214Full text available |
14 |
Material Type: Article
|
![]() |
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal CancerJournal of clinical oncology, 2018-03, Vol.36 (8), p.773-779 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.9901 ;PMID: 29355075Full text available |
15 |
Material Type: Article
|
![]() |
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant TherapyJournal of clinical oncology, 2020-10, Vol.38 (29), p.3388-3397 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00549 ;PMID: 32749941Full text available |
16 |
Material Type: Article
|
![]() |
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast CancerJournal of clinical oncology, 2020-10, Vol.38 (28), p.3261-3272 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02750 ;PMID: 32663119Full text available |
17 |
Material Type: Article
|
![]() |
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)Journal of clinical oncology, 2020-06, Vol.38 (18), p.2053-2061 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03296 ;PMID: 32343640Full text available |
18 |
Material Type: Article
|
![]() |
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal CancerJournal of clinical oncology, 2020-05, Vol.38 (14), p.1569-1579 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02503 ;PMID: 32160096Full text available |
19 |
Material Type: Article
|
![]() |
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Journal of clinical oncology, 2018-07, Vol.36 (20), p.2017-2023 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.8034 ;PMID: 29746227Full text available |
20 |
Material Type: Article
|
![]() |
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemicAnnals of oncology, 2020-08, Vol.31 (8), p.1065-1074 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020 The Author(s) 2020 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.05.009 ;PMID: 32442581Full text available |